Birth weight and gestational age distributions in a rural Kenyan population.
Birthweight
Fetal growth
Gestational age
Kenya
Obstetrical ultrasound
Sub-Saharan Africa
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
08 03 2023
08 03 2023
Historique:
received:
20
06
2022
accepted:
21
02
2023
entrez:
8
3
2023
pubmed:
9
3
2023
medline:
11
3
2023
Statut:
epublish
Résumé
With the increased availability of access to prenatal ultrasound in low/middle-income countries, there is opportunity to better characterize the association between fetal growth and birth weight across global settings. This is important, as fetal growth curves and birthweight charts are often used as proxy health indicators. As part of a randomized control trial, in which ultrasonography was utilized to establish accurate gestational age of pregnancies, we explored the association between gestational age and birthweight among a cohort in Western Kenya, then compared our results to data reported by the INTERGROWTH-21st study. This study was conducted in 8 geographical clusters across 3 counties in Western Kenya. Eligible subjects were nulliparous women carrying singleton pregnancies. An early ultrasound was performed between 6 + 0/7 and 13 + 6/7 weeks gestational age. At birth, infants were weighed on platform scales provided either by the study team (community births), or the Government of Kenya (public health facilities). The 10 A total of 1291 infants (of 1408 pregnant women randomized) were included. Ninety-three infants did not have a measured birth weight. The majority of these were due to miscarriage (n = 49) or stillbirth (n = 27). No significant differences were found between subjects who were lost to follow-up. Signed rank comparisons of the observed median of the Western Kenya data at 10 A comparison of birthweight percentiles by gestational age estimation, among a sample of infants from rural Kenya, revealed slight differences as compared to those from the global population (INTERGROWTH-21 This is a single site sub-study of data collected in conjunction with the Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) Trial, which is listed at ClinicalTrials.gov , NCT02409680 (07/04/2015).
Sections du résumé
BACKGROUND
With the increased availability of access to prenatal ultrasound in low/middle-income countries, there is opportunity to better characterize the association between fetal growth and birth weight across global settings. This is important, as fetal growth curves and birthweight charts are often used as proxy health indicators. As part of a randomized control trial, in which ultrasonography was utilized to establish accurate gestational age of pregnancies, we explored the association between gestational age and birthweight among a cohort in Western Kenya, then compared our results to data reported by the INTERGROWTH-21st study.
METHODS
This study was conducted in 8 geographical clusters across 3 counties in Western Kenya. Eligible subjects were nulliparous women carrying singleton pregnancies. An early ultrasound was performed between 6 + 0/7 and 13 + 6/7 weeks gestational age. At birth, infants were weighed on platform scales provided either by the study team (community births), or the Government of Kenya (public health facilities). The 10
RESULTS
A total of 1291 infants (of 1408 pregnant women randomized) were included. Ninety-three infants did not have a measured birth weight. The majority of these were due to miscarriage (n = 49) or stillbirth (n = 27). No significant differences were found between subjects who were lost to follow-up. Signed rank comparisons of the observed median of the Western Kenya data at 10
CONCLUSIONS
A comparison of birthweight percentiles by gestational age estimation, among a sample of infants from rural Kenya, revealed slight differences as compared to those from the global population (INTERGROWTH-21
TRIAL REGISTRATION
This is a single site sub-study of data collected in conjunction with the Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) Trial, which is listed at ClinicalTrials.gov , NCT02409680 (07/04/2015).
Identifiants
pubmed: 36890485
doi: 10.1186/s12887-023-03925-2
pii: 10.1186/s12887-023-03925-2
pmc: PMC9993805
doi:
Substances chimiques
Aspirin
R16CO5Y76E
Banques de données
ClinicalTrials.gov
['NCT02409680']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
112Subventions
Organisme : Eunice Kennedy Shriver National Institute of Child Health and Human Development
ID : 5UG1HD076461-10
Informations de copyright
© 2023. The Author(s).
Références
BMC Pregnancy Childbirth. 2021 Jun 25;21(1):443
pubmed: 34172018
Pediatr Res. 1975 Feb;9(2):76-83
pubmed: 1118194
Malar J. 2019 Jul 12;18(1):233
pubmed: 31299976
Acta Paediatr. 2017 Jun;106(6):904-911
pubmed: 28240381
J Matern Fetal Neonatal Med. 2020 Jun;33(11):1906-1912
pubmed: 30614334
J Epidemiol Community Health. 2013 Dec 1;67(12):999-1005
pubmed: 23851150
Reprod Health. 2020 Dec 17;17(Suppl 3):176
pubmed: 33334365
Lancet Glob Health. 2020 Nov;8(11):e1427-e1434
pubmed: 33069303
BMC Pregnancy Childbirth. 2012 Mar 19;12:15
pubmed: 22429731
J Matern Fetal Neonatal Med. 2016 Mar;29(6):872-4
pubmed: 25853216
PLoS Med. 2017 Jan 24;14(1):e1002220
pubmed: 28118360
Obstet Gynecol. 2017 May;129(5):e150-e154
pubmed: 28426621
Glob Health Sci Pract. 2016 Dec 28;4(4):675-683
pubmed: 28031304
BJOG. 2021 Jan;128(1):101-109
pubmed: 32659031
Arch Gynecol Obstet. 2017 May;295(5):1061-1077
pubmed: 28285426
Ultrasound Obstet Gynecol. 2020 May;55(5):613-620
pubmed: 31364201
Ultrasound Obstet Gynecol. 2017 Apr;49(4):478-486
pubmed: 27804212
Curr Probl Diagn Radiol. 2017 May - Jun;46(3):210-215
pubmed: 28057388
Reprod Health. 2020 Dec 17;17(Suppl 3):187
pubmed: 33334356
Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:193-8
pubmed: 27337415
PLoS One. 2020 Sep 24;15(9):e0239320
pubmed: 32970719
Ultrasound Obstet Gynecol. 2018 Jul;52(1):44-51
pubmed: 29696704
Reprod Health. 2020 Nov 30;17(Suppl 2):184
pubmed: 33256769
Lancet. 2020 Jan 25;395(10220):285-293
pubmed: 31982074
J Obstet Gynaecol. 2022 Feb;42(2):244-247
pubmed: 34027820
BMC Pediatr. 2013 Apr 20;13:59
pubmed: 23601190
Clin Obstet Gynecol. 2010 Sep;53(3):673-80
pubmed: 20661051
Annu Rev Nutr. 2019 Aug 21;39:121-146
pubmed: 31091416
Reprod Health. 2015;12 Suppl 2:S12
pubmed: 26063483
Nutrients. 2019 Oct 21;11(10):
pubmed: 31640153
J Nutr. 2008 Mar;138(3):581-6
pubmed: 18287370
Reprod Health. 2020 Nov 30;17(Suppl 2):159
pubmed: 33256778
Popul Health Metr. 2021 Feb 8;19(Suppl 1):13
pubmed: 33557841
BMJ Open. 2013 Dec 05;3(12):e003650
pubmed: 24319272
Am J Perinatol. 2017 Mar;34(4):409-414
pubmed: 27627793
Pediatr Res. 1975 Feb;9(2):70-6
pubmed: 1118193
Am J Trop Med Hyg. 2013 Jan;88(1):48-53
pubmed: 23166193
BMC Pregnancy Childbirth. 2017 May 3;17(1):135
pubmed: 28468653
Obstet Gynecol Clin North Am. 2021 Jun;48(2):371-385
pubmed: 33972072
Ultrasound Obstet Gynecol. 2021 Mar;57(3):409-416
pubmed: 33073889
Hippokratia. 2020 Jul-Sep;24(3):133-137
pubmed: 34239291
Tanzan J Health Res. 2008 Jul;10(3):137-43
pubmed: 19024338
Obstet Gynecol. 2014 Oct;124(4):863-866
pubmed: 25244460
Lancet. 2014 Sep 6;384(9946):857-68
pubmed: 25209487
Ultraschall Med. 2015 Dec;36(6):630-6
pubmed: 25014478
J Ultrasound Med. 2016 Aug;35(8):1713-24
pubmed: 27353069
Lancet Glob Health. 2020 Jul;8(7):e942-e953
pubmed: 32562650
J Paediatr Child Health. 2021 May;57(5):677-683
pubmed: 33314475
Ultrasound Med Biol. 2018 Nov;44(11):2250-2260
pubmed: 30093339
Semin Perinatol. 2019 Aug;43(5):267-272
pubmed: 31003635
BJOG. 2018 Jan;125(2):131-138
pubmed: 28139875
Semin Perinatol. 2019 Aug;43(5):297-307
pubmed: 31005357
Lancet. 2014 Sep 6;384(9946):869-79
pubmed: 25209488